Company Name: Eidos Therapeutics, Inc.
Eidos Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company’s area of therapeutic focus is on diseases caused by transthyretin amyloidosis.
Ticker Symbol: EIDX (NASDAQ)
Company Website: https://eidostx.com
Social Media:
Headquarters: San Francisco, CA